Purchase Order VA580Q14028
Award Date 4/21/11
Potential Completion Date 5/21/11
Potential Value $4.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the Provant Therapy System, a proprietary medical device developed by Regenesis Biomedical Inc. The $7,203.90 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) through VA Integrated Service Network 17. The contract is for the supply and rental of the Provant Therapy System, which is indicated for the palliative treatment of post-operative pain and edema. The contract was awarded as a purchase order and is not associated with any...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System and related rental services. The $7,142.85 firm-fixed-price purchase order contract, awarded on February 2, 2011, with a completion date of March 2, 2011, was not set aside for any preference program. Regenesis Biomedical Inc. is the prime contractor and is providing its proprietary Provant...
- This federal contract award is for the purchase of the Provant Therapy System from Regenesis Biomedical Inc., a medical technology company. The $4,820.98 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) on December 28, 2010, with an ultimate completion date of January 28, 2011. The contract was awarded against Regenesis Biomedical's existing GSA Schedule 65-II-A contract for medical equipment and supplies, and did not utilize any set-aside designations....
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical technology company, to provide the Provant Therapy System and related rental services. The $7,145.56 firm-fixed-price purchase order contract has an ultimate completion date of February 24, 2011. Regenesis Biomedical Inc. is the prime contractor and does not utilize any subcontractors for this work. The contract is not associated with any set-aside program. The Provant...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System and related rental services. The contract, valued at $4,820.98, was awarded on a firm fixed-price basis with a completion date of February 20, 2011. It was issued as a purchase order and did not utilize any set-aside designations. Regenesis Biomedical Inc. provides the Provant Therapy System, a...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the company's Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of May 8, 2011 and was awarded through Regenesis Biomedical's existing GSA Schedule...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The $7,055.10 firm-fixed-price purchase order is for the provision of the Provant Therapy System, a patented noninvasive regenerative medicine product developed by Regenesis Biomedical. The contract, which does not utilize any set-aside, is awarded against Regenesis Biomedical's GSA Schedule 65-II-A contract for medical equipment and supplies. The...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System, a noninvasive regenerative medicine product. The $4,820.98 firm-fixed-price purchase order contract was awarded on January 10, 2011, with a completion date of February 10, 2011. The contract was awarded under Regenesis Biomedical's General Services Administration (GSA) Schedule 65-II-A for...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $7,142.85 firm fixed-price purchase order contract is for the provision of Regenesis Biomedical's Provant Therapy System, a patented noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract is not associated with any set-aside designations. Regenesis Biomedical,...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, to provide the Provant Therapy System and related rental services. The $4,820.98 firm-fixed-price purchase order contract has an ultimate completion date of December 23, 2010. The contract is not associated with a set-aside program. It appears to be part of Regenesis Biomedical's ongoing work to supply the VA with its patented Provant...